180 related articles for article (PubMed ID: 19300081)
1. Interferon and heart disease.
Angerio AD
Crit Care Nurs Q; 2009; 32(2):159-62. PubMed ID: 19300081
[TBL] [Abstract][Full Text] [Related]
2. Interferon gamma: a master regulator of atherosclerosis.
McLaren JE; Ramji DP
Cytokine Growth Factor Rev; 2009 Apr; 20(2):125-35. PubMed ID: 19041276
[TBL] [Abstract][Full Text] [Related]
3. [The current opinion on inflammatory, biochemistry and hemostatic markers and factors in atherosclerosis. Part II].
Rajtar R; Kloch M; Bober M; Kolasińska-Kloch W
Przegl Lek; 2006; 63(9):767-72. PubMed ID: 17479867
[TBL] [Abstract][Full Text] [Related]
4. Cytokine dysregulation in chronic kidney disease: how can we treat it?
Carrero JJ; Yilmaz MI; Lindholm B; Stenvinkel P
Blood Purif; 2008; 26(3):291-9. PubMed ID: 18421214
[TBL] [Abstract][Full Text] [Related]
5. RA patients at high risk for early heart disease. Researchers call for aggressive control of RA disease activity to curb chronic inflammation.
Health News; 2006 Sep; 12(9):9-10. PubMed ID: 17144015
[No Abstract] [Full Text] [Related]
6. Linking CKD and heart disease.
Nephrol News Issues; 2005 Mar; 19(4):S1, S8. PubMed ID: 15813312
[No Abstract] [Full Text] [Related]
7. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
8. [The immune system in atherosclerosis. Immunomodulatory or anti-inflammatory treatment that is effective against atherosclerosis and its complications are needed to ensure the hypothesis].
Frostegård J
Lakartidningen; 2013 Oct 23-29; 110(43-44):1931-4. PubMed ID: 24340436
[No Abstract] [Full Text] [Related]
9. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?
Nordestgaard BG; Zacho J
Nutr Metab Cardiovasc Dis; 2009 Oct; 19(8):521-4. PubMed ID: 19695857
[TBL] [Abstract][Full Text] [Related]
10. [Diabetic dyslipoproteinemia: beyond LDL].
Merkel M
Dtsch Med Wochenschr; 2009 May; 134(20):1067-73. PubMed ID: 19421932
[TBL] [Abstract][Full Text] [Related]
11. Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study.
McGill HC; McMahan CA; Gidding SS
Circulation; 2008 Mar; 117(9):1216-27. PubMed ID: 18316498
[No Abstract] [Full Text] [Related]
12. Introduction. Review of major recent findings supporting treatments to control advanced plaques of atherosclerosis.
Insull W
Am J Med; 2009 Jan; 122(1 Suppl):S1-2. PubMed ID: 19110083
[No Abstract] [Full Text] [Related]
13. An emerging paradigm in atherosclerosis: focus on subclinical disease.
Miller M
Postgrad Med; 2009 Mar; 121(2):49-59. PubMed ID: 19332962
[TBL] [Abstract][Full Text] [Related]
14. High marks for below-average cholesterol. For the best protection against clogged arteries and heart disease, average cholesterol no longer makes the grade--lower is better.
Harv Heart Lett; 2006 Feb; 16(6):4-5. PubMed ID: 19662696
[No Abstract] [Full Text] [Related]
15. [Inflammation and C-reactive protein in cardiovascular disease].
Munk PS; Larsen AI
Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
[TBL] [Abstract][Full Text] [Related]
16. The grapefruit-drug interaction debate: role of statins.
Reamy BV; Stephens MB
Am Fam Physician; 2007 Jul; 76(2):190, 192; author reply 192. PubMed ID: 17695563
[No Abstract] [Full Text] [Related]
17. More than skin deep: atherosclerosis as a systemic manifestation of psoriasis.
Alexandroff AB; Pauriah M; Camp RD; Lang CC; Struthers AD; Armstrong DJ
Br J Dermatol; 2009 Jul; 161(1):1-7. PubMed ID: 19500102
[TBL] [Abstract][Full Text] [Related]
18. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
[TBL] [Abstract][Full Text] [Related]
19. No cancer bonus for statin therapy.
Harv Heart Lett; 2006 Mar; 16(7):6. PubMed ID: 19663033
[No Abstract] [Full Text] [Related]
20. Drug combinations and all cause mortality in heart disease: use of statins is not supported by study.
Vos E
BMJ; 2005 Jul; 331(7509):159; author reply 160. PubMed ID: 16020861
[No Abstract] [Full Text] [Related]
[Next] [New Search]
